Antibe Therapeutics Inc(Pre-Merger) T.ATE

Alternate Symbol(s): ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

TSX:ATE - Post by User

Antibe Therapeutics Inc(Pre-Merger)

Bullboard Posts

Comment by Fintech99on Mar 13, 2020 8:54pm

87 Views

Post# 30806776

RE:RE:RE:Odd ...

The halts were a result of the sheer volume of shares being either sold or bought. The selloff over that last few days triggered the entire exchange to halt trading for 15 minutes as a preventative "cooling off" each time and we had a trigger go off for the buy up this morning. Annoying considering I was discount shopping and didn't get a few order filled. Nothing to worry and not ATE specific.

Nice run up on ATE on the bell this morning too, we were back up 10+% before the halt.. still holding on though.

Stay calm and take advantage of the folks giving up their positions.

Bullboard Posts

Silvercorp to expand into Ecuador with C$200M Adventus acquisition